Alexion plans phase 2 study of Soliris in COVID-19 in coming days: report

7th April 2020 Uncategorised 0

The race for a COVID-19 therapeutic has attracted many of the biggest names in biopharma, and now Alexion is getting ready to place a bet on its own Soliris, GlobalData reports. 

More: Alexion plans phase 2 study of Soliris in COVID-19 in coming days: report
Source: fierce